swiss
Roche offers $43.7B for Genentech
Read the full article: http://eastbay.bizjournals.com/eastbay/stories/2008/07/21/da...
Roche Holding has offered to buy the rest of Genentech, about a 44% stake it doesn't already own, for $89 a share, or about $43.7 billion.
The deal would mark one of the Swiss drug maker's biggest acquisitions and would mean about $750 million to $850 million in pre-tax savings.
Vested Interest:
None- Login or register to post comments
- Read more
- Email this page
Related Articles
- Roche offers $43.7B for Genentech
- Biotech Sector Could Jump 25% on Roche-Genentech Deal
- GenVec, Inc.’s (GNVC) TNFerade™ Gets FDA Fast Track Designation for Pancreatic Cancer Treatment
- Drugstore.com, Inc. (DSCM) Announces Third Quarter Financial Results; Expects Profitability in the Fourth Quarter
- China Pharma Holdings Inc. (CPHI.OB) Posts Positive Q3 Results Across the Board